INTEGRA LIFESCIENCES HOLDINGS CORP — Form 8-K
Filed October 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 52/100
What the filing says
Integra LifeSciences priced $450M of 9.500% senior secured notes due 2033, expected to close October 19, 2026. Proceeds will refinance existing credit facilities and pay transaction fees. Notes are guaranteed by wholly-owned domestic subsidiaries and were offered only to qualified institutional buyers under Rule 144A.
Why this rating
Refinancing transaction worth ~49% of market cap—material in scale but routine in nature; no operational change, debt restructuring, or strategic shift disclosed.
See more from October 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.